SCHEMBL25285641

SCHEMBL25285641

CC(C)(C)N1C[C@H](N2C(=O)CCC2=O)C[C@H](N2C(=O)CCC2=O)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.32
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22098592 0.69 VNN1 (0.38) ATM
SCHEMBL14155801 0.69 ATM (0.34) ATM
SCHEMBL12193292 0.69 ATM (0.34) ATM
SCHEMBL23126193 0.69 ATM (0.34) ATM
SCHEMBL22098594 0.68 VNN1 (0.39) —
SCHEMBL23555243 0.67 ATM (0.33) ATM
SCHEMBL24352596 0.67 ATM (0.33) ATM
SCHEMBL18713121 0.67 ATM (0.33) ATM
SCHEMBL13727484 0.66 CHRNB2 (0.39) —
SCHEMBL24378705 0.66 ATM (0.32) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204441-A1 INSULIN RECEPTOR PARTIAL AGONISTS Merck Sharp & Dohme LLC (US) 2023-07-05 — — EP disclosed
WO-2022046739-A1 INSULIN RECEPTOR PARTIAL AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-03-03 — — WO disclosed
Send feedback